TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
DNTH

Dianthus Therapeutics Inc.

Healthcare · Biotechnology · —

96.80$ -4.3% vs. previous close Closing price · As of: Sep 18, 2026

Investor relations

Report Dates

Investor relations overview for Dianthus Therapeutics Inc. (DNTH): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/04/2026.

Next report 11/04/2026
Last report 08/04/2026
Earnings surprise by quarter (%)
Q3 23 · -575.0 % 23 Q4 23 · 29.7 % 23 Q1 24 · -22.7 % 24 Q2 24 · 7.3 % 24 Q3 24 · -23.3 % 24 Q4 24 · -6.6 % 24 Q1 25 · -15.5 % 25 Q2 25 · -2.3 % 25 Q3 25 · -12.8 % 25 Q4 25 · -38.7 % 25 Q1 26 · 22.7 % 26 Q2 26 · 3.2 % 26

EPS estimate beaten

Full history 18 of 36 quarters (50%)
Last 16 quarters 6 of 16 quarters (38%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 08/04/2026 Dianthus Therapeutics, Inc. /DE/ (DNTH): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?